Android app Apple app link

TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

By Yahoo! Finance   |   1 month ago
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

Adam Waldman expects BRIUMVI's market share in the anti-CD 20 market for MS to grow to the mid-50s or even 60% by 2025.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.